In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
On March 31, 2026, the popular HTTP client Axios experienced a supply chain attack, causing two newly published npm packages ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results